(HealthDay)—A swallowable cellular retrieval capsule sponge cytology-sampling device, EsophaCap, in combination with a methylation biomarker panel represents a promising strategy
Continue reading »
Researchers identify promising proteins for diagnostic, prognostic use in ALS
Researchers from North Carolina State University have identified proteins that may be useful in both earlier diagnosis of Amyotrophic Lateral
Continue reading »
MDM2 inhibitors could be promising new treatment for uveitis
Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness. Fortunately, blindness and eye
Continue reading »
Anti-reflux surgery promising in idiopathic pulmonary fibrosis
(HealthDay)—Laparoscopic antireflux surgery is safe and well-tolerated in patients with idiopathic pulmonary fibrosis (IPF) and abnormal acid gastroesophageal reflux (GER),
Continue reading »
Promising novel treatment against Alzheimer disease
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses
Continue reading »
Breast Cancer Drug Promising in Phase 3 Trial
WEDNESDAY, Aug. 15, 2018 — For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an
Continue reading »
Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer
Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1
Continue reading »
Researchers discover antidepressant could be a promising treatment for Primary Biliary Cholangitis
Gail Wright considered herself healthy. She had no idea she had a chronic liver disease. “I was at a routine
Continue reading »
Researchers find a promising new approach for treating liver cirrhosis
Increased pressure in the veins leading to the liver, known as portal hypertension (PH), accounts for the majority of medical
Continue reading »
Certolizumab looks promising for moderate-to-severe psoriasis
(HealthDay)—Twice-weekly certolizumab biologic appears to be both safe and effective for the treatment of moderate-to-severe chronic plaque psoriasis, according to
Continue reading »